Dialysis device

Inactive Publication Date: 2012-02-02
DEBIOTECH SA
View PDF4 Cites 113 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0010]It is an object of the present invention to at least partly overcome one or more of the above identified limitations of prior art. Specifically it is an object to provide an improved dialysis device securing that a treatment objective is reached while allowing flexibility in the individual treatment sessions. This may be achieved by means of a dialysis device comprising a prescriber

Problems solved by technology

However, the devices provided with a patient interface, such as are described in the prior art, are not programmed in such a way as to define therapeutic or clinical objectives to be achieved, for example a predefined creatinine clearance value, a given dose defined as a Kt/V ratio where K=clea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dialysis device
  • Dialysis device
  • Dialysis device

Examples

Experimental program
Comparison scheme
Effect test

example i

[0083]Patient B according to the above exemplified treatment plan, may want to shorten the duration of the treatment session from 5 to 4 hours on a particular day. If this new duration of treatment is within the set limits the modification is allowed.

[0084]Based on a modified setting the re-evaluation means determines how other treatment settings may be changed to achieve the therapeutic objectives and suggests at least one treatment option. The re-evaluation means may also take into account other available data of the patient such as the treatment history and current treatment parameters when suggesting new treatment options to achieve the therapeutic objectives.

example ii

[0085]Patient A according to the above exemplified treatment plan, has gained 3.0 kg since the last treatment session, a weight which has to be taken off to reach the therapeutic objective of the dry weight. The maximum allowed weight loss rate may have been set to 800 g / hour, in which case the maximum total weight loss that may be achieved in the prescribed 2.5 hour treatment is 2.0 kg. The re-evaluation means suggests a treatment option where the duration of the treatment is prolonged to 3 hours and 45 minutes, which allows the dry weight to be reached while maintaining a safe weight removal rate. The re-evaluation means may suggest a second treatment option, where a weight loss of only 2.0 kg in the current treatment session is reached, leaving a “debt” until the next treatment session.

example iii

[0086]During a treatment of Patient B, the maximum blood flow that may be achieved is 300 ml / min due to that the needles have been somewhat misplaced during cannulation. This is lower than the blood flow of 350 ml / min according to the entered treatment plan. Thus, the treatment dose (spKt / V=1.2) will not be reached as planned. The re-evaluation means suggests a treatment option showing an increase of the dialysis fluid flow rate from 500 to 800 ml / min. If increase of dialysis fluid flow is not sufficient to reach the treatment dose objective, additionally the re-evaluation means will suggest a treatment option where the treatment time is extended. Alternatively, the re-evaluation means may suggest a treatment option resulting in that a dose “debt” is left for the next treatment session or treatment sessions.

[0087]As exemplified above, there may be one or several options for the patient to choose from to reach the therapeutic objective.

[0088]In one embodiment of the invention the pat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A dialysis device comprising a prescriber interface and a programming means configured to allow, via the prescriber interface, input of a set of therapeutic objectives and a treatment plan and a re-evaluation means configured to, as a function of the therapeutic objectives and the treatment plan, suggest at least one treatment option comprising a set of settings of a treatment session to achieve said set of therapeutic objectives.

Description

FIELD OF THE INVENTION[0001]The present invention concerns the field of dialysis treatment. It relates more particularly to a dialysis device comprising an automated peritoneal dialysis machine or a hemodialysis machine that, based on input of certain data, is programmed to carry out a treatment session.BACKGROUND OF THE INVENTION[0002]Treatment of a patient with renal insufficiency is typically carried out according to a treatment plan created by a prescriber, such as a physician, based on certain therapeutic objectives. The treatment plan may comprise a schedule of treatment sessions and specific settings for each scheduled treatment session. The treatment plan typically also includes dietary advice, medications, frequency of blood samples for follow-up etc.[0003]Treatment of renal insufficiency typically takes place in individual treatment sessions. One session may have duration between 1 and 12 hours.[0004]Certain conditions may effect the actual execution of the treatment plan ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G06Q50/00B01D61/00
CPCA61M1/16A61M1/28A61M2205/505A61M1/1613G06Q50/22G06F19/3481A61M2205/52A61M2205/3393A61M2205/502A61M1/3609G16H40/20G16H20/40G16H40/63G16H20/17
Inventor NEFTEL, FREDERICBERNARD, PASCALHERTZ, THOMAS
Owner DEBIOTECH SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap